Circulating Tumor Material in Colorectal Cancer and Melanoma
Completed
- Conditions
- Colorectal Cancer and Melanoma
- Interventions
- Other: blood collection
- Registration Number
- NCT02907086
- Lead Sponsor
- Abramson Cancer Center at Penn Medicine
- Brief Summary
Observational study to allow the collection of blood and medical information to evaluate the role of circulating tumor material in patients with colorectal cancer and melanoma
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 7
Inclusion Criteria
-
The subject must be a patient at the Hospital of the University of Pennsylvania
- Patients with presumed stage II, III, or IV colorectal cancer with planned surgical resection of either the primary tumor or metastatic lesion(s) being evaluated at the Hospital of the University of Pennsylvania
- Patients with histologically confirmed melanoma stage IIb, IIc, IIIa, IIIb, or IIIc/IV scheduled for surgical resection being evaluated at the Hospital of the University of Pennsylvania.
-
The subject must be able to provide informed consent or have an acceptable surrogate capable of giving consent on the subject's behalf.
-
The subject must be 18 years of age or older.
Exclusion Criteria
- The subject is not able to provide informed consent.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description melanoma blood collection - colorectal cancer blood collection -
- Primary Outcome Measures
Name Time Method Number of blood samples collected 24 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Abramson Cancer Center of the University of Pennsylvania
🇺🇸Philadelphia, Pennsylvania, United States